VPC
BBNX

Vestal Point Capital’s Beta Bionics BBNX Stock Holding History

Vestal Point Capital’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Sell
1,600,000
-611,518
-28% -$7.27M 0.59% 40
2026
Q1 		$22.2M Buy
2,211,518
+1,611,518
+269% +$23.8M 0.62% 47
2025
Q4 		$18.3M Hold
600,000
– – 0.62% 39
2025
Q3 		$11.9M Buy
600,000
+50,000
+9% +$879K 0.54% 50
2025
Q2 		$8.01M Buy
+550,000
New +$7.79M 0.42% 46

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Vestal Point Capital's BBNX Position: Q2 2026 in Review

Vestal Point Capital reduced its Beta Bionics (BBNX) stake by 28% in Q2 2026, selling an estimated $7.27M and leaving 1,600,000 shares worth $25.1M. The position accounts for 0.59% of the portfolio, ranked #40.

Vestal Point Capital first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Vestal Point Capital held 1,600,000 shares of Beta Bionics worth $25.1M as of Q2 2026.
  • Vestal Point Capital sold 611,518 Beta Bionics shares in Q2 2026, an estimated $7.27M.
  • Beta Bionics made up 0.59% of Vestal Point Capital's portfolio in Q2 2026, its #40 holding.
  • Vestal Point Capital first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.